| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | n/a | -530.0% |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 1.6 | 7.5 |
| Pr/Book | n/a |
| Latest | F'cast | |
|---|---|---|
| Revenue | n/a | -91.1% |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-07 | 0.40 | (16.54) | (84.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-08 | 5.94 | (17.40) | (84.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-09 | 6.33 | (11.08) | (53.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-10 | 4.59 | (6.11) | (16.45)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-11 | 7.16 | (2.72) | (5.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-12 | 1.00 | (5.30) | (0.05)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-13 | 3.50 | (2.60) | (0.02)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-14 | 6.50 | 0.30 | 0.00p | 3,187.5 | n/a | n/a | n/a | 0.0% |
Copyright © 2013 FactSet Research Systems Inc. All rights reserved.
| Directorate Change | 11-Jun-2013 | 16:23 | RNS |
| Migration of Shares | 31-May-2013 | 12:43 | RNS |
| French Registration of Insect Repellent Product | 11-Apr-2013 | 07:00 | RNS |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 6.38p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 6.50 |
| 52 Week Low | 3.13 |
| Volume | 0 |
| Shares Issued | 117.35m |
| Market Cap | £7.48m |
| RiskGrade | 219 |
| Value | ![]() |
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 1 |
| Buy | 0 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 1 |

| No dividends found |
| CFO | Peter K. Jerome |
| CEO | Steve Crummett |
You are here: research